ASX - Delayed Quote AUD

The Calmer Co International Limited (CCO.AX)

0.0040 0.0000 (0.00%)
At close: April 26 at 11:54 AM GMT+10
Key Events
Loading Chart for CCO.AX
DELL
  • Previous Close 0.0040
  • Open 0.0040
  • Bid 0.0040 x --
  • Ask 0.0050 x --
  • Day's Range 0.0040 - 0.0040
  • 52 Week Range 0.0020 - 0.0080
  • Volume 750,000
  • Avg. Volume 5,069,912
  • Market Cap (intraday) 4.731M
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Calmer Co International Limited operates as a medicinal kava health and wellness company in Australia, New Zealand, Fiji, and the United States. It produces and sells noble kava extract capsules, root powder mixes, and teas under the Fiji Kava brand; hemp and CBD oils under Danodan brand; drinking kava and flavoured shots under the Taki Mai brand; and kava beverages under leilo brand names. The company also produces nutraceuticals; and sells t-shirts. In addition, it sells its products through fijikava.com. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in West End, Australia.

www.thecalmerco.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CCO.AX

Performance Overview: CCO.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CCO.AX
42.86%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

CCO.AX
14.29%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

CCO.AX
--
S&P/ASX 200 [XJO]
0.00%

5-Year Return

CCO.AX
--
S&P/ASX 200 [XJO]
0.00%

Compare To: CCO.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CCO.AX

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    5.32M

  • Enterprise Value

    7.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.09

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    3.06

  • Enterprise Value/EBITDA

    -1.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -182.94%

  • Return on Assets (ttm)

    -64.42%

  • Return on Equity (ttm)

    -1,064.19%

  • Revenue (ttm)

    2.46M

  • Net Income Avi to Common (ttm)

    -4.5M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    612.88k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.37M

Company Insights: CCO.AX

People Also Watch